Rose Sotolongo
Podiatrist · Ridgeland, MSNPI 1790779858
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Amgen at 28.0% of the total. 2025 is the largest year on record at $470, 4.1 times the $114 reported in 2019.
Across 88 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$490
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$260
- ANI Pharmaceuticals, Inc.$245
- Averitas Pharma Inc.$145
- Smith+Nephew$102
- Convatec Inc.$86
- plus $421 from 13 others
What the payments were for
- Food & beverage$1,67596%
- Education$744%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 35 | $490 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $260 |
| ANI Pharmaceuticals, Inc. | 15 | $245 |
| Averitas Pharma Inc. | 5 | $145 |
| Smith+Nephew | 4 | $102 |
| Convatec Inc. | 3 | $86 |
| Kowa Pharmaceuticals America, Inc. | 4 | $78 |
| GRT US Holding, Inc. | 4 | $77 |
| Organogenesis Inc. | 2 | $47 |
| Melinta Therapeutics, LLC | 3 | $36 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Bone Support Inc. | 1 | $25 |
| Biotissue Holdings Inc. | 1 | $24 |
| Reprise Biomedical, Inc. | 1 | $21 |
| Medtronic | 1 | $19 |
| Inari Medical, Inc. | 1 | $17 |
| Kerecis Limited | 1 | $15 |
| Merck | 1 | $14 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JUBLIA$224
How this compares
$1,749 in reported general payments places this provider in the 85th percentile of 28 podiatrist providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 180 | $7,999 |
| Daptomycin | 52 | $7,896 |
| CiclopiroxCiclopirox Olamine | 163 | $6,532 |
| Ketoconazole | 131 | $3,728 |
| Gabapentin | 345 | $3,130 |
| Mupirocin | 254 | $2,240 |
| Allopurinol | 181 | $1,757 |
| Colchicine | 42 | $1,515 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 19 | $1,310 |
| Doxycycline Hyclate | 136 | $1,277 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 191 | $1,240 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 154 | $1,204 |
| Febuxostat | 19 | $1,041 |
| Terbinafine Hcl | 120 | $921 |
| Celecoxib | 66 | $914 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Ridgeland
- Carla MartinOlive Branch$9K
- Shelley BrandWaynesboro$7K
- Clint JirouxNew Albany$2K
- Percy AndersonJackson$2K
- Carey WilliamsOxford$2K
- Elizabeth TiceJackson$2K
- Stefanie ThomasClinton$2K
- Mohammad ParsaMadison$1K
- Gerard GuerinBiloxi$1K
- Brian ShockleyVicksburg$863
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.